Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 diabetes with ASCVD therapy choiceau-racpau-amc

A 63-year-old man with type 2 diabetes and established coronary artery disease (previous NSTEMI) has HbA1c 60 mmol/mol (7.6%) despite maximal metformin. eGFR is 58 mL/min/1.73 m². Which additional agent is preferred for glucose lowering and cardiovascular benefit?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.